Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence

Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disease, is characterized by telangiectases and arteriovenous malformations (AVMs). Untreated AVMs, especially in the lungs—pulmonary AVMs (PAVMs)—can result in morbidity with a decreased life expectancy. We have investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: de Gussem, Els M., Kroon, Steven, Hosman, Anna E., Kelder, Johannes C., Post, Martijn C., Snijder, Repke J., Mager, Johannes J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694763/
https://www.ncbi.nlm.nih.gov/pubmed/33172103
http://dx.doi.org/10.3390/jcm9113581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694763/
https://www.ncbi.nlm.nih.gov/pubmed/33172103
http://dx.doi.org/10.3390/jcm9113581

Ejemplares similares